Showing results (11-20 of 45) with videos related to
Sort By:
Pageof 5
Leukemia & Lymphoma|June 1, 1995
Differentiation of extramedullary acute promyelocytic leukemia by all-trans-retinoic acidC A Lederman, J Weisberger, K Seiter, et al.Gastroenterology|May 1, 1976
Effects of oral versus intravenous nutrition on intestinal adaptation after small bowel resection in the dogE J Feldman, R H Dowling, J McNaughton, et al.Leukemia|January 1, 1995
Pilot study of all-trans retinoic acid as post-remission therapy in patients with acute promyelocytic leukemiaK Seiter, W H Miller, E J Feldman, et al.Leukemia|January 1, 1996
Homoharringtonine in patients with myelodysplastic syndrome (MDS) and MDS evolving to acute myeloid leukemiaE J Feldman, K P Seiter, T Ahmed, et al.Cancer|October 1, 1996
Graft-versus-host disease. Possible higher risk for African American patientsS J Easaw, D E Lake, M Beer, et al.Gastroenterology|February 1, 1983
Effect of enteral feeding on the maintenance of gastric acid secretory functionP E Hyman, E J Feldman, M E Ament, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Phase I clinical and laboratory evaluation of topotecan and cytarabine in patients with acute leukemiaK Seiter, E J Feldman, H D Halicka, et al.Apoptosis : an International Journal on Programmed Cell Death|January 1, 1997
Cell cycle specificity of apoptosis during treatment of leukaemiasH D Halicka, K Seiter, E J Feldman, et al.Acta Haematologica|January 1, 1989
Philadelphia chromosome (Ph1)-positive acute lymphoblastic leukemia (ALL) is resistant to effective therapy for Ph1-negative ALLZ A Arlin, E J Feldman, T Ahmed, et al.Leukemia & Lymphoma|July 27, 2016
Preliminary Experience with Short Course High-Dose Mitoxantrone in Combination with High-Dose Cytarabine in Patients with Acute Leukemia and Blastic Phase of Chronic Myelogenous LeukemiaE J Feldman, S Biguzzi, T Ahmed, et al.Pageof 5